checkAd

Bayer Subsidiary BlueRock Therapeutics Starts Phase 1 Trial in Patients with Advanced Parkinson’s Disease

(PLX AI) – Bayer subsidiary BlueRock Therapeutics announces first patient dosed in Canada in Phase 1 Trial for Advanced Parkinson’s Disease.It's an open-label trial of pluripotent stem cell-derived dopaminergic neurons in patients with advanced …

  • (PLX AI) – Bayer subsidiary BlueRock Therapeutics announces first patient dosed in Canada in Phase 1 Trial for Advanced Parkinson’s Disease.
  • It's an open-label trial of pluripotent stem cell-derived dopaminergic neurons in patients with advanced Parkinson’s disease
  • The purpose of the Phase 1 clinical trial is to evaluate the safety, tolerability and preliminary efficacy of DA01 in patients with Parkinson’s disease

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 65,96€, was eine Steigerung von +4,98% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
Übernehmen
Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
WerbungDisclaimer
Wertpapier


0 Kommentare
Autor: PLX AI
 |  574   |  0   |   

Schreibe Deinen Kommentar

Disclaimer

Bayer Subsidiary BlueRock Therapeutics Starts Phase 1 Trial in Patients with Advanced Parkinson’s Disease (PLX AI) – Bayer subsidiary BlueRock Therapeutics announces first patient dosed in Canada in Phase 1 Trial for Advanced Parkinson’s Disease.It's an open-label trial of pluripotent stem cell-derived dopaminergic neurons in patients with advanced …

Nachrichten des Autors

Titel
Ørsted Buys Onshore Wind Farm in USA
Renault to Sell Renault Russia, Controlling Interest in AVTOVAZ; Can Buy It Back in 6 Years
Ørsted Jumps 5% as Goldman Sees Over 40% Upside
Vestas Introducing 4.5 MW Wind Turbine for Medium to Low Wind Conditions
McDonald's to Sell Russian Business
Trifork Raises Outlook for 2022
Take-Two Q4 Earnings Beat Expectations; Gives New Guidance
Aktia Bank Says Life Insurance Unit Signs LOI to Sell Real Estate Investment for Over EUR 10 ...
Peloton Settles All Litigation with iFIT
DSV a Rare Opportunity Buy at Current Valuation, Goldman Says
Titel
Nel Q1 Revenue NOK 213 Million vs. Estimate NOK 248 Million
Evotec Q1 Adjusted EBITDA EUR 18.9 Million
Hexagon Purus Q1 Revenue Tops Estimates
K+S Q1 EBITDA Beats Estimates as High Prices Offset Lower Volumes, Energy Costs
Bayer Q1 Earnings Much Better Than Expected; Outlook Confirmed
Bilfinger Q1 Revenue Beats Expectations; Outlook Confirmed
Norwegian Air Posts Q1 EBIT Loss NOK 849 Million; Has NOK 7.5 Billion Cash Left
Thyssenkrupp Q2 Earnings Much Better Than Expected; Raises Outlook
GAM Holding Says Release Purporting to Show Support to Luna Is Fake
SMA Solar Q1 Earnings Beat Consensus; Outlook Unchanged
Titel
Dentsply Sirona Fired CEO Casey; Board Member Groetelaars Takes Over Temporarily
Telefonica Subsidiary Telefonica Tech Buys BE-terna Group for up to EUR 350 Million
Plug Power Gets Contract to Deliver Green Hydrogen to Walmart
Plug Power Q1 Revenue Below Expectations; Keeps FY Targets Unchanged
TeamViewer Q1 Adjusted EBITDA EUR 83.2 Million vs. Estimate EUR 62 Million
Nel Q1 Revenue NOK 213 Million vs. Estimate NOK 248 Million
Tomra Systems Q1 EBITA NOK 237 Million vs. Estimate NOK 248 Million
Sixt Hit by Cyber Attack, Says Impact Was Minimized
Vonovia Q1 Net Income EUR -29.1 Million
AbbVie Q1 Adj. EPS Tops Estimates; Guidance Cut on Milestone Expense
Titel
Nokia Reinstated with Neutral Rating at Bank of America
Stillfront buys Jawaker for USD 205 Million in Cash and Shares; to Issue New Shares for SEK 1 ...
Dentsply Sirona Fired CEO Casey; Board Member Groetelaars Takes Over Temporarily
Viatris Sells Biosimilars Portfolio to Biocon Biologics for up to $3.335 Bilion
Novo Nordisk Rises as Wegovy Demand Leads to Shortage in U.S.
Rexel Buys Mayer for Enterprise Value $456 Million
Biomerieux Buys Specific Diagnostics for Price Equivalent to 3.3% of Market Cap
Nordex Rises as Bank of America Sees Strong Orders in Q3
Plug Power Q4 Revenue Beats Expectations; Sees Fuel Margins Breakeven by 2023
Amazon Jumps 7% After Earnings; Takes $11.8 Billion Gain from Rivian